Also
- Share via
Allergan Inc. said a U.S. federal appeals court ruled in favor of the company in a patent infringement suit against Apotex Inc., a Canadian generic-drug maker. The ruling bars Apotex from obtaining Food and Drug Administration approval to market a generic version of Irvine-based Allergan’s eye drug Acular.
